172 related articles for article (PubMed ID: 37043085)
21. Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and
Zhou J; Guo B; Zhu W; Sui X; Ma X; Qian J; Cao L; Han C
Pharm Dev Technol; 2021 Jan; 26(1):81-91. PubMed ID: 33070668
[TBL] [Abstract][Full Text] [Related]
22. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
[TBL] [Abstract][Full Text] [Related]
23. Biomimetic Surface-Enhanced Raman Scattering Nanoparticles with Improved Dispersibility, Signal Brightness, and Tumor Targeting Functions.
Srivastava I; Xue R; Jones J; Rhee H; Flatt K; Gruev V; Nie S
ACS Nano; 2022 May; 16(5):8051-8063. PubMed ID: 35471820
[TBL] [Abstract][Full Text] [Related]
24. Long circulation and tumor-targeting biomimetic nanoparticles for efficient chemo/photothermal synergistic therapy.
Zhang Y; Yue X; Yang S; Li X; Cui L; Cui X; Shi Y; Liu Z; Guo X; Li Y
J Mater Chem B; 2022 Jul; 10(26):5035-5044. PubMed ID: 35726686
[TBL] [Abstract][Full Text] [Related]
25. Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury.
Guo X; Hong T; Zang J; Shao R; Hou X; Wang K; Liu W; Su F; He B
J Nanobiotechnology; 2022 Dec; 20(1):531. PubMed ID: 36514154
[TBL] [Abstract][Full Text] [Related]
26. Stealth Polydopamine-Based Nanoparticles with Red Blood Cell Membrane for the Chemo-Photothermal Therapy of Cancer.
Wang H; Williams GR; Xie X; Wu M; Wu J; Zhu LM
ACS Appl Bio Mater; 2020 Apr; 3(4):2350-2359. PubMed ID: 35025285
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of mesoporous silica/polyglutamic acid peptide dendrimer with dual targeting and its application in dissolving thrombus.
Huang M; Zhang SF; Lü S; Qi T; Yan J; Gao C; Liu M; Li T; Ji Y
J Biomed Mater Res A; 2019 Aug; 107(8):1824-1831. PubMed ID: 31012233
[TBL] [Abstract][Full Text] [Related]
28. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of a novel nanoparticle carrying urokinase used in targeted thrombolysis.
Zhong Y; Gong WJ; Gao XH; Li YN; Liu K; Hu YG; Qi JS
J Biomed Mater Res A; 2020 Feb; 108(2):193-200. PubMed ID: 31581363
[TBL] [Abstract][Full Text] [Related]
30. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
[TBL] [Abstract][Full Text] [Related]
31. Thrombus-targeted nano-agents for NIR-II diagnostic fluorescence imaging-guided flap thromboembolism multi-model therapy.
Cao Z; Zhang X; Wei Z; Song C; Zou H; Ran J; Zhang H; Xie D; Han S; Wang Y; Cai Y; Han W
J Nanobiotechnology; 2022 Oct; 20(1):447. PubMed ID: 36242039
[TBL] [Abstract][Full Text] [Related]
32. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
[TBL] [Abstract][Full Text] [Related]
33. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
[TBL] [Abstract][Full Text] [Related]
34. Black Phosphorus Nanosheets Induced Oxidative Stress
Zhong Y; Lin Y; Chen Y; Chen G; Zhang J; Li L; Huang A; Zhang L; Ma Y; Xie ZY; Liao Q
ACS Appl Bio Mater; 2021 Feb; 4(2):1704-1719. PubMed ID: 35014517
[TBL] [Abstract][Full Text] [Related]
35. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.
Wang S; Wang R; Meng N; Guo H; Wu S; Wang X; Li J; Wang H; Jiang K; Xie C; Liu Y; Wang H; Lu W
J Control Release; 2020 Dec; 328():78-86. PubMed ID: 32853731
[TBL] [Abstract][Full Text] [Related]
36. RGD functionalized polymeric nanoparticles targeting periodontitis epithelial cells for the enhanced treatment of periodontitis in dogs.
Yao W; Xu P; Zhao J; Ling L; Li X; Zhang B; Cheng N; Pang Z
J Colloid Interface Sci; 2015 Nov; 458():14-21. PubMed ID: 26197107
[TBL] [Abstract][Full Text] [Related]
37. A Synergistic and Efficient Thrombolytic Nanoplatform: A Mechanical Method of Blasting Combined with Thrombolytic Drugs.
Hu L; Xu J; Zhang W; Wang J; Fang N; Luo Y; Xu L; Liu J; Zhang Y; Ran H; Guo D; Zhou J
Int J Nanomedicine; 2022; 17():5229-5246. PubMed ID: 36388875
[TBL] [Abstract][Full Text] [Related]
38. RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy.
Yadav B; Chauhan M; Shekhar S; Kumar A; Mehata AK; Nayak AK; Dutt R; Garg V; Kailashiya V; Muthu MS; Sonali ; Singh RP
Int J Pharm; 2023 Feb; 633():122587. PubMed ID: 36623741
[TBL] [Abstract][Full Text] [Related]
39. Cyclic RGD functionalized PLGA nanoparticles loaded with noncovalent complex of indocyanine green with urokinase for synergistic thrombolysis.
Zhang S; Li J; Ren J; Xue Z; Qi X; Si Q
Front Bioeng Biotechnol; 2022; 10():945531. PubMed ID: 36032719
[TBL] [Abstract][Full Text] [Related]
40. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
Xu J; Zhao JH; Liu Y; Feng NP; Zhang YT
Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
